Enhanced passivation process to protect silicon prior to high dose implant strip

Information

  • Patent Grant
  • 8721797
  • Patent Number
    8,721,797
  • Date Filed
    Wednesday, December 8, 2010
    14 years ago
  • Date Issued
    Tuesday, May 13, 2014
    10 years ago
Abstract
Improved methods and apparatus for stripping photoresist and removing ion implant related residues from a work piece surface are provided. According to various embodiments, the workpiece is exposed to a passivation plasma, allowed to cool for a period of time, and then exposed to an oxygen-based or hydrogen-based plasma to remove the photoresist and ion implant related residues. Aspects of the invention include reducing silicon loss, leaving little or no residue while maintaining an acceptable strip rate. In certain embodiments, methods and apparatus remove photoresist material after high-dose ion implantation processes.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This applications claims benefit under 34 USC §119(e) to U.S. Provisional Patent Application No. 61/285,918, filed Dec. 11, 2009, which is incorporated by reference herein.


FIELD OF INVENTION

The present invention pertains to methods and apparatuses to remove or strip photoresist material and removing related residues from a work piece surface. In certain embodiments, this application relates to methods and apparatus for stripping resist after ion implant or plasma assisting doping implant (low dose or high-dose implanted resist).


BACKGROUND

Photoresist is a light sensitive material used in certain fabrication processes to form a patterned coating on a work piece, e.g., a semiconductor wafer, during processing. After exposing the photoresist coated surface to a pattern of high energy radiation, a portion of the photoresist is removed to reveal the surface below, leaving the rest of the surface protected. Semiconductor processes such as etching, depositing, and ion implanting are performed on the uncovered surface and the remaining photoresist. After performing one or more semiconductor processes, the remaining photoresist is removed in a strip operation.


SUMMARY OF THE INVENTION

Improved methods and apparatus for stripping photoresist and removing ion implant related residues from a work piece surface are provided. According to various embodiments, the workpiece is exposed to a passivation plasma, allowed to cool for a period of time, and then exposed to an oxygen-based or hydrogen-based plasma to remove the photoresist and ion implant related residues. Aspects of the invention include reducing silicon loss, leaving little or no residue while maintaining an acceptable strip rate. In certain embodiments, methods and apparatus remove photoresist material after high-dose ion implantation processes.


One aspect of the invention relates to a method of removing material from a work piece surface in a reaction chamber, and involves exposing the work piece to a plasma generated from forming gas; after exposing the work piece to the forming gas plasma, allowing the wafer to sit in a non-plasma environment for a time period of at least 30 seconds; and after allowing the wafer to sit, exposing the wafer to an oxygen- or hydrogen-based plasma to remove the material.


According to various embodiments, the work piece is allowed to sit for at least about 100 seconds, at least about 150 seconds, at least about 200 seconds, or at least about 220 seconds.


In certain embodiments, at least one of the oxygen- or hydrogen-based plasma includes fluorine species; in other embodiments, neither does. The material removed from the work piece surface may be a high-dose implanted resist. In certain embodiments, the forming gas plasma is remotely generated. In certain embodiments, a protective film forms on exposed silicon portions of the workpiece after exposure to the forming gas plasma. The protective film may be a SixNy film.


Another aspect of the invention relates to an apparatus for removing material from a work piece surface including a reaction chamber including a plasma source, a showerhead positioned downstream of the plasma source, and a work piece support downstream of the showerhead, said work piece support comprising a pedestal and temperature-controlling mechanism to control a temperature of a work piece supported on the work piece support; and a controller for executing a set of instructions, said set of instruction including instructions for exposing the work piece to a plasma generated from forming gas; after exposing the work piece to the forming gas plasma, allowing the wafer to sit in a non-plasma environment for a time period of at least 30 seconds; and after allowing the wafer to sit, exposing the wafer to an oxygen- or hydrogen-based plasma to remove the material.


These and other features and advantages of the present invention will be described in more detail below with reference to the associated drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-1D depict various stages of semiconductor device fabrication before and after ion implantation and stripping operations.



FIG. 2 is a process flow diagram illustrating operations in accordance with certain embodiments of the present invention.



FIG. 3 is a graph showing silicon loss as a function of post-passivation wait time.



FIG. 4 is a schematic illustration showing an apparatus suitable for implementing aspects of the present invention.



FIG. 5 shows a multi-station sequential architecture suitable for implementing aspects of the present invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Introduction

In the following detailed description of the present invention, numerous specific embodiments are set forth in order to provide a thorough understanding of the invention. However, as will be apparent to those skilled in the art, the present invention may be practiced without these specific details or by using alternate elements or processes. In other instances well-known processes, procedures and components have not been described in detail so as not to unnecessarily obscure aspects of the present invention.


In this application, the terms “work piece”, “semiconductor wafer”, “wafer” and “partially fabricated integrated circuit” will be used interchangeably. One skilled in the art would understand that the term “partially fabricated integrated circuit” can refer to a silicon wafer during any of many stages of integrated circuit fabrication thereon. The following detailed description assumes the invention is implemented on a wafer. However, the invention is not so limited. The work piece may be of various shapes, sizes, and materials. In addition to semiconductor wafers, other work pieces that may take advantage of this invention include various articles such as displays, printed circuit boards, and the like.


Photoresist is a light sensitive material used in certain fabrication processes to form a patterned coating on a work piece, e.g., a semiconductor wafer, during processing. After exposing the photoresist coated surface to a pattern of high energy radiation, a portion of the photoresist is removed to reveal the surface below, leaving the rest of the surface protected. Semiconductor processes such as etching, depositing, and ion implanting are performed on the uncovered surface and the remaining photoresist. After performing one or more semiconductor processes, the remaining photoresist is removed in a strip operation.


During ion implantation, dopant ions, e.g., ions of boron, boron difluoride, indium, gallium, thallium, phosphorous, arsenic, antimony, bismuth, or germanium, are accelerated toward a work piece target. The ions implant in exposed regions of the work piece as well as in the remaining photoresist surface. The process may form well regions (source/drain) and lightly doped drain (LDD) and doubled diffused drain (DDD) regions. The ion implant impregnates the resist with the implant species and depletes the surface of hydrogen. The outer layer or crust of the resist forms a carbonized layer that may be much denser than the underlying bulk resist layer. These two layers have different thermal expansion rates and react to stripping processes at different rates.


The difference between the outer layer and bulk layer is quite pronounced in post high-dose ion implant resist. In high-dose implantation, the ion dose may be greater than 1×1015 ions/cm2 and the energy may be from 10 Kev to greater than 100 keV. Traditional high dose implantation strip (HDIS) processes employ oxygen chemistries where monatomic oxygen plasma is formed away from the process chamber and then directed at the work piece surface. The reactive oxygen combines with the photoresist to form gaseous by-products which is removed with a vacuum pump. For HDIS, additional gases are needed to remove the implanted dopants with oxygen.


Primary HDIS considerations include strip rate, amount of residue, and film loss of the exposed and underlying film layer. Residues are commonly found on the substrate surface after HDIS and stripping. They may result from sputtering during the high-energy implant, incomplete removal of crust, and/or oxidation of implant atoms in the resist. After stripping, the surface should be residue free or substantially residue free to ensure high yield and eliminate the need for additional residue removal processing. Residues may be removed by overstripping, i.e., a continuation of the strip process past the point nominally required to remove all photoresist. Unfortunately, in conventional HDIS operations, overstripping sometimes removes some of the underlying functional device structure. At the device layer, even very little silicon loss from the transistor source/drain regions may adversely affect device performance and yield, especially for ultra shallow junction devices fabricated at the <32 nm design rule or below.


As mentioned previously, the methods and apparatus of the invention may be used to efficiently and effectively to remove photoresist materials after high-dose ion implantation. The invention is not limited to high-dose implant strip (HDIS). The invention is also not limited to any particular category of dopants implanted. For instance, described methods and apparatus may be effectively used with stripping after medium or low dose implant. Although specific dopant ions such as boron, arsenic, and phosphorous are discussed, the described methods and apparatus may be effectively used to strip resist impregnated with other dopants, such as nitrogen, oxygen, carbon, germanium, and aluminum.


The methods and apparatus of the present invention use passivation plasmas that are produced from forming gas. The methods and apparatus also use photoresist stripping and ion removal plasmas that are generated from plasmas gases that contain oxygen and/or hydrogen. In certain embodiments, the gases also contain a fluorine-containing gas, a weak oxidizing agent and one or more additional components. One skilled in the art will recognize that the actual species present in the plasma may be a mixture of different ions, radicals, and molecules derived from the particular gases used to generate the plasmas described herein. For example, it is noted that other species may be present in the reaction chamber, such as small hydrocarbons, carbon dioxide, water vapor and other volatile components as the plasma reacts with and breaks down the organic photoresist and other residues. One of skill in the art will also recognize that the initial gas/gases introduced into the plasma is/are often different from the gas/gases that exist in the plasma as well as the gas/gases contact the work piece surface during strip.



FIG. 1A to 1D depicts various stages of semiconductor fabrication before and after ion implantation and stripping operations. FIG. 1A shows a semiconductor substrate 101 coated with photoresist material 103. The substrate 101 may include one or more layers of deposited film, e.g., oxide film, silicide contact, and/or polysilicon film, or may be a bare silicon substrate, including for example a silicon-on-insulator type substrate. Initially, the photoresist material coats the entire substrate surface. The photoresist is then exposed to patterned radiation generated through a mask and developed to remove a portion of the material, e.g., the opening 104 shown in FIG. 1A between the remaining photoresist materials 103.


The substrate is then exposed to an ion implant process. During ion implant, the surface of the work piece or wafer is implanted with dopant ions. The process may be, for example, a plasma-immersion ion implantation (PIII) or ion beam implantation. The ions bombard the substrate surface, including the exposed silicon layer 101 and the photoresist 103. With high energy ion implantation, small amounts of the underlying material 107 may be sputtered to the photoresist sidewalls. See FIG. 1B. This material may include some of the implant species, other material in the plasma or ion beam, and by-products of the implantation. They include silicon, aluminum, carbon, fluorine, titanium, other contact materials such as cobalt, and oxygen in both elemental and compound form. The actual species depend on the composition of the substrate before ion implant, the photoresist, and the implanted species.


At the exposed silicon layer 101, a doped region 109 is created. The ion energy or intensity of the bombardment determines the depth or thickness of the doped region. The density of the ion flux determines the extent of doping.


The ions also impregnate the photoresist surface creating a crust layer 105. The crust layer 105 may be carbonized and highly cross-linked polymer chains. The crust is usually depleted of hydrogen and impregnated with the implant species. The crust layer 105 is denser than the bulk resist layer 103. The relative density depends on the ion flux while the thickness of the crust layer depends on the ion energy.


This crust layer 105 is harder to strip than the bulk photoresist 103 below. Removal rates of the crust layer may be 50% or 75% slower than the underlying bulk Enhanced Passivation process to protect Silicon prior to High Dose Implant Enhanced Passivation process to protect Silicon prior to High Dose Implant photoresist. The bulk photoresist contains relatively high levels of chemically bonded nitrogen and some of its original casting solvent. At elevated wafer temperature, e.g., above 150 to above 200° C., the bulk resist can outgas and expand relative to the crust layer. The entire photoresist can then “pop” as the underlying bulk photoresist builds up pressure under the crust. Photoresist popping is a source of particles and process defects because the residues are especially hard to clean from the wafer surface and chamber internal parts. With high-dose ion implantation, the density difference between the crust and underlying bulk photoresist layer is even higher. The crust may also be thicker.



FIG. 1C shows the substrate after a strip that fails to completely remove the photoresist 103 and the sidewall sputter residue 107. The sidewall sputter residue 107 may include particles that do not form a volatile compound under conventional strip chemistries. These particles may remain after a conventional strip operation. The residue may also include oxides of implanted species formed with the reactive oxygen used in oxygen-based strip chemistries, such as boron oxide and arsenic oxide. Portions of the crust 105 may also remain on the substrate. Crust sidewalls and corners at the bottom of photoresist vias may be hard to strip because of geometries. These residue particles may be removed by overstripping in some cases, using fluorinated chemistry, or wet cleaning the wafer.


Silicon loss is a function of resist thickness, crust thickness, and percent overstrip. Longer and more aggressive stripping to remove thicker resist can also remove more silicon. For resist with thicker crust, the difference between the crust layer and bulk resist layer is even more pronounced. The thicker crust sidewalls and corners are even harder to strip. Thus, strip processes designed to remove thick crust also tends to remove more silicon. Overstrip may be used to address resist uniformity and geometries in addition to residue removal. Overstrip is a continuation of the strip process past the point nominally required to remove all photoresist. If the photoresist is totally removed in some areas of the wafer but not others, continuation of the strip process would cause additional material, typically silicon and silicon oxide, to be removed from areas that are already stripped.



FIG. 1D shows the substrate after all residue has been removed. According to various embodiments, the residue is removed without additional silicon loss or oxidation and with minimum delay. In certain embodiments, the strip process leaves no residue and thus reduces the number of process steps.


Provided herein are methods to reduce silicon loss for high dose implant strip (HDIS) processes, although as noted above, the methods may be effectively used with stripping after medium or low dose implant or other photoresist stripping processes. The methods described herein provide a passivation layer to prevent silicon loss prior to stripping and are not limited to a particular stripping chemistry.



FIG. 2 is a process flow diagram 200 illustrating operations in a method according to certain embodiments. First, a wafer having photoresist and implant residue material is provided in an operation 201. The wafer may be provided to a chamber capable of containing a plasma. Although not depicted, the wafer is optionally pre-heated (prior to, during, or after operation 201) to a set temperature low enough to prevent popping, but high enough to provide energy for formation of a passivation layer and an acceptable etch rate in further operations. The wafer is then exposed to a plasma generated from forming gas an operation 203. The forming gas comprises hydrogen and an inert dilutant, such as, for example, nitrogen, helium, or the like, or a combination thereof. In an exemplary embodiment of the invention, the forming gas is about 0.5 to about 10 molar percent (%) hydrogen. In a particular embodiment of the invention, the forming gas is about 3 to about 6% hydrogen, e.g., 4% hydrogen. In certain embodiments, pure nitrogen gas with essentially no hydrogen is used. It has been found that pure nitrogen can provide as similar passivation effect as forming gas.


The wafer is exposed to the forming gas plasma for a period of time, e.g., on the order of about 10 to 90 seconds, e.g., about 20 to 40 seconds. In many embodiments, the plasma is a remotely-generated plasma, though it may be an in-situ plasma. In certain embodiments, the plasma is generated from a gas consisting essentially of forming gas. In other embodiments, other species may be added. In certain embodiments, substantially no oxygen or fluorine is present in the gases inlet to the plasma generator.


Then in an operation 205, the plasma is extinguished and the wafer sits for a period of time. In certain embodiments, the wafer is allowed to cool during this operation, for example to about 35 C. Without being bound by a particular theory, it is believed that a protective surface forms on the exposed silicon to slow prevent oxidation or etching from subsequent oxygen-based or hydrogen-based stripping chemistries that may include fluorine species. The protective surface may be a SixNy film.


It was unexpectedly found that the wait time between operation 203 and the subsequent stripping operations is critical to reducing silicon loss. FIG. 3 is a graph showing silicon loss (Angstroms) as a function of wait time (seconds) between exposure to the forming gas plasma, and a subsequent stripping process using a hydrogen-based chemistry containing fluorine. The silicon loss decreases sharply as the wait time increases, eventually leveling off around 220 seconds. According to various embodiments, the wait time is at least about 30 seconds, at least about 60 seconds, at least about 100 seconds, at least about 120 seconds, at least about 140 seconds, at least about 160 seconds, at least about 180 seconds, at least about 200 seconds, at least about 220 seconds, at least about 240, at least about 260 seconds, or at least about 280 seconds. The effect observed in FIG. 3 is unexpected as the chemical kinetics of the reaction to form a SixNy film would be expected to be much faster.


Once the waiting period is finished, a stripping process is performed in an operation 207. The stripping process may use one or more oxygen-based or hydrogen-based plasmas. In certain embodiments, the stripping chemistry additionally contains fluorine species in one or more operations. Fluorine compounds that may be fed to the plasma generator to generate such species include nitrogen trifluoride (NF3), sulfur hexafluoride (SF6), hexafluoroethane (C2F6), tetrafluoromethane (CF4), trifluoromethane (CHF3), difluoromethane (CH2F2), octofluoropropane (C3F8), octofluorocyclobutane (C4F8), octofluoro[1-]butane (C4F8), octofluoro[2-]butane (C4F8), octofluoroisobutylene (C4F8), fluorine (F2), and the like.


While the methods described herein are not limited to any particular strip chemistries, examples plasmas to remove photoresist and HDI residue include plasmas generated from the following:


O2/NF3


O2/CF4


O2/N2


H2/CO2/NF3


H2/CO2/CF4


H2/CO2/NF3/CF4


H2/CO2


H2/N2


In many embodiments, multiple operations having different chemistries are performed to fully remove the photoresist and residue. In certain embodiments, forming gas is added to one or more of these HDI strip operations. For example, in certain embodiments, forming gas is added to all non-fluorine containing plasma operations. It has been found that using forming gas or pure nitrogen in the fluorine-containing stations can adversely affect silicon loss. Without being bound by a particular theory, it is believed that this may be due to nitrogen in the forming gas facilitating the disassociation of the NF3, releasing more F— ions. Typically, no significant wait time is imposed after these operations, though in certain embodiments, it may be. Examples are:

    • O2/FG with forming gas supplying about 14-25% by volume;
    • H2/CO2/FG with forming gas supplying about 40-60% by volume;


It should be noted that the passivation process described in operations 203 and 205 may be performed or repeated at other stages in the process, e.g., between one or more strip operations. In certain embodiments, only operation 203 is inserted between these operations.


Plasma Generation


Various types of plasma sources may be used in accordance with the invention, including RF, DC, and microwave based plasma sources. In a preferred embodiment, a downstream RF plasma source is used. Typically, the RF plasma power for a 300 mm wafer ranges between about 300 Watts to about 10 Kilowatts. In some embodiments, the RF plasma power is between about 2000 Watts and 5000 Watts, e.g., 3500 W.


Showerhead Assembly


According to various embodiments of the present invention the plasma gas is distributed to the work surface via a showerhead assembly. The showerhead assembly may be grounded or have an applied voltage to attract some charge species while not affecting the flow of neutral species to the wafer, e.g., 0-1000 watt bias. Many of the electrically charged species in the plasma recombine at the showerhead. The assembly includes the showerhead itself which may be a metal plate having holes to direct the plasma and inert gas mixture into the reaction chamber. The showerhead redistributes the active hydrogen from the plasma source over a larger area, allowing a smaller plasma source to be used. The number and arrangement of the showerhead holes may be set to optimize strip rate and strip rate uniformity. If the plasma source is centrally located over the wafer, the showerhead holes are preferably smaller and fewer in the center of the showerhead in order to push the active gases toward the outer regions. The showerhead may have at least 100 holes. Suitable showerhead include the Gamma xPR showerhead or the GxT drop-in showerhead available from Novellus Systems, Inc. of San Jose, Calif. In embodiments in which there is no showerhead assembly, the plasma enters the process chamber directly.


Process Chamber


The process chamber may be any suitable reaction chamber for the strip operation being performed. It may be one chamber of a multi-chambered apparatus or it may simply be a single chamber apparatus. The chamber may also include multiple stations where different wafers are processed simultaneously. The process chamber may be the same chamber where the implant, etch, or other resist-mediated process takes place. In other embodiments, a separate chamber is reserved for the strip. Process chamber pressure may range from about 600 mTorr to 2 Torr. In certain embodiments, the pressure ranges from about 0.9 Torr to 1.5 Torr.


The process chamber includes one or more processing stations on which strip operations are performed. In certain embodiments, the one or more processing stations includes a preheat station, at least one strip station, and an over-ash station. The wafer support is configured to support the wafer during processing. The wafer support may also transfer heat to and from the wafer during processing to adjust the wafer temperature as necessary. In certain embodiments, the wafer is supported on a plurality of minimum contacts and does not physically contact the wafer support surface plane. A spindle picks up the wafer and transfers the wafer from one station to another.



FIG. 4 is a schematic illustration showing aspects of a downstream plasma apparatus 400 suitable for practicing the present invention on wafers. This apparatus may be used both for passivation and strip operations. Apparatus 400 has a plasma producing portion 411 and an exposure chamber 401 separated by a showerhead assembly 417. Inside exposure chamber 401, a wafer 403 rests on a platen (or stage) 405. Platen 405 is fitted with a heating/cooling element. In some embodiments, platen 405 is also configured for applying a bias to wafer 403. Low pressure is attained in exposure chamber 401 via vacuum pump via conduit 407. Sources of gaseous hydrogen (with or without dilution/carrier gas) and carbon dioxide (or other weak oxidizing agent) provide a flow of gas via inlet 409 into plasma producing portion 411 of the apparatus. Plasma producing portion 411 is surrounded in part by induction coils 413, which are in turn connected to a power source 415. During operation, gas mixtures are introduced into plasma producing portion 411, induction coils 413 are energized and a plasma is generated in plasma producing portion 411. Showerhead assembly 417 may have an applied voltage or be grounded directs the flow of species into exposure chamber 401. As mentioned, wafer 403 may be temperature controlled and/or a RF bias may be applied. Various configurations and geometries of the plasma source 411 and induction coils 413 may be used. For example, induction coils 413 may loop around the plasma source 411 in an interlaced pattern. In another example, the plasma source 411 may be shaped as a dome instead of a cylinder. A controller 450 may be connected to components of the process chamber, and control process gas composition, pressure, temperature and wafer indexing of the stripping operations. Machine-readable media may be coupled to the controller and contain instructions for controlling process conditions for these operations.


Suitable plasma chambers and systems include the Gamma 2100, 2130 I2CP (Interlaced Inductively Coupled Plasma), G400, and GxT offered by Novellus Systems, Inc. of San Jose, Calif. Other systems include the Fusion line from Axcelis Technologies Inc. of Rockville, Md., TERA21 from PSK Tech Inc. in Korea, and the Aspen from Mattson Technology Inc. in Fremont, Calif. Additionally, various strip chambers may be configured onto cluster tools. For example, a strip chamber may be added to a Centura cluster tool available from Applied Materials of Santa Clara, Calif.


Work Piece


In preferred embodiments, the work piece used in accordance with the methods and apparatus of the invention is a semiconductor wafer. Any size wafer may be used. Most modern wafer fabrication facilities use either 200 mm or 300 mm wafers. As disclosed above, the process and apparatus disclosed herein strips photoresist after a processing operation such as etching, ion implant, or deposition. The present invention is suitable for wafers having very small features or critical dimensions, e.g., sub 100 nm, at 65 nm, or at or less than 45 nm. The low silicon loss feature of the HDIS as disclosed is particularly suitable for very shallow junctions of advanced logic devices. The present invention is also specifically suitable for wafers undergoing front end of the line (FEOL) ion implantation, especially high-dose ion implantation.


The plasma-activated species reacts with the photoresist and sputter residue on the wafer. At the wafer, the reactive gas may include a number of plasma activated species, radicals, charged species, and gas by-products. For hydrogen-based plasmas, the volume concentration of various hydrogen species may be about 20-80% of the gas at the wafer, typically over 50%. For oxygen-based plasmas, the volume concentration of various oxygen species may be about 20-80% of the gas at the wafer, typically over 50%. The volume concentration of various fluorine species may be 0.01% to about 2% or less than 1%. The volume concentration of various species from the weak oxidizing agent may be 0.05 to about 5% or about 1.2%. These species may include H2*, H2+, H+, H*, e-, OH, O*, CO, CO2, H2O, HF, F*, F—, CF, CF2, and CF3.


Process conditions may vary depending upon the wafer size. In some embodiments of the invention, it is desired to keep the work piece at a particular temperature during the application of plasmas to its surface. Wafer temperatures can range between about 110 degrees and about 500 degrees Celsius. To reduce the likelihood of photoresist popping described above, wafer temperature is preferably increased slowly until enough crust has been removed and photoresist popping ceases to be a concern. Initial station temperature may be about 110 degrees to about 260 degrees Celsius, for example, about 240 degrees Celsius. Later stations can use higher temperatures such as 285 degrees Celsius and about 350 degrees Celsius successfully with good strip rates. In certain embodiments, the temperature is lowered during NF3 spikes to reduce Si loss associated with these spikes.


EXAMPLE PROCESSES

As indicated above, in certain embodiments, a multi-station strip apparatus is employed to perform the photoresist and residue stripping processes described herein. FIG. 5 is a simplified schematic showing a top view of such an apparatus including stations 1, 2, 3, 4, 5 and 6. Wafers enter the apparatus at station 1 via chamber 501, are transferred to each station in sequence for a processing operation at that station and exit from station 6 via chamber 502 after the process is complete. The architecture permits pausing or cooling the wafer after the passivation process to protect against silicon erosion by HDIS strip chemistries.


Example Process 1

















Temperature


Station
Chemistry
Time
(C.)







1 - Preheat
No gas
18 seconds
240


2 - FG passivation -
FG
18 seconds
240


plasma exposure


2 - post-passivation
FG (plasma off)
220 seconds 
240


wait


3-4
H2/CO2/NF3
18 seconds per
285




station


5-6
H2/CO2/FG
18 seconds per
350




station









Example Process 2

















Temperature


Station
Chemistry
Time
(C.)







1 - FG passivation -
FG
 18 seconds
240


plasma exposure


1 - post-passivation
FG (plasma off)
220 seconds


wait


2-4
H2/CO2/NF3
18 seconds per
285




station


5-6
H2/CO2/FG
18 seconds per
350




station









In another example process, a first pass on 6 stations is performed to provide the forming gas passivation, followed by pre-heat in station 1 and strip operations in stations 2-6 in a second pass. The waiting operation may take place outside the chamber, in a non-oxidative environment.


The disclosed methods and apparatus may be implemented in systems including lithography and/or patterning hardware for semiconductor fabrication. Further, the disclosed methods may be implemented in a process with lithography and/or patterning processes preceding or following the disclosed methods.


Experimental

Various experiments were conducted comparing Si loss when the forming gas passivation in station 1 preceded F-containing strip operations in stations 2-6 to Si loss when no passivation process was performed. Silicon loss was reduced by 54%-82%.


While this invention has been described in terms of a few preferred embodiments, it should not be limited to the specifics presented above. Many variations on the above-described preferred embodiments may be employed. Therefore, the invention should be broadly interpreted with reference to the following claims.

Claims
  • 1. A method of removing photoresist from a work piece surface in a reaction chamber, the method comprising: exposing the work piece to a first plasma generated from forming gas or pure nitrogen, wherein photoresist is on the work piece surface during the exposure to the first plasma;after exposing the work piece to the first plasma, allowing the work piece to sit in a non-plasma environment for a time period of at least 30 seconds;and after allowing the work piece to sit, exposing the work piece to a second oxygen- or hydrogen-based plasma to remove the photoresist, wherein the first and second plasmas have different chemistries.
  • 2. The method of claim 1, wherein the work piece is allowed to sit for at least 100 seconds.
  • 3. The method of claim 1, wherein the work piece is allowed to sit for at least 150 seconds.
  • 4. The method of claim 1, wherein the work piece is allowed to sit for at least 200 seconds.
  • 5. The method of claim 1, wherein the work piece is allowed to sit for at least 220 seconds.
  • 6. The method of claim 1, wherein the second oxygen- or hydrogen-based plasma comprises fluorine species.
  • 7. The method of claim 1, wherein the photoresist removed from the work piece surface comprises a high-dose implanted resist.
  • 8. The method of claim 1, wherein the first plasma is remotely generated.
  • 9. The method of claim 1, wherein a protective film forms on exposed silicon portions of the work piece as a result of exposure to the first plasma while the work piece is allowed to sit.
  • 10. The method of claim 9 wherein the protective film is a SixNy film.
  • 11. The method of claim 1, wherein exposing the work piece is performed after a lithography operation.
  • 12. A method of removing material from a work piece surface in a reaction chamber, the method comprising: exposing the work piece to a first plasma generated from forming gas or pure nitrogen in the reaction chamber, wherein the work piece has photoresist thereon;after exposing the work piece to the first plasma, allowing the work piece to sit in a non-plasma environment in the reaction chamber for a time period of at least 30 seconds;and after allowing the work piece to sit, exposing the work piece to a second oxygen- or hydrogen-based plasma to remove the photoresist, wherein the first and second plasmas have different chemistries.
  • 13. A method of removing material from a work piece surface in a reaction chamber, the method comprising: exposing the work piece to a first plasma generated from forming gas or pure nitrogen, wherein the work piece has photoresist thereon;after exposing the work piece to the first plasma, allowing the work piece to sit in a non-plasma environment in the reaction chamber for a time period of at least 30 seconds;and after allowing the work piece to sit, exposing the work piece to a second oxygen- or hydrogen-based plasma to remove the photoresist, wherein the work piece is maintained in a vacuum environment during the method, and wherein the first and second plasmas have different chemistries.
US Referenced Citations (220)
Number Name Date Kind
4201579 Robinson et al. May 1980 A
4357203 Zelez Nov 1982 A
4699689 Bersin Oct 1987 A
5122225 Douglas Jun 1992 A
5158644 Cheung et al. Oct 1992 A
5292393 Maydan et al. Mar 1994 A
5354386 Cheung et al. Oct 1994 A
5593541 Wong et al. Jan 1997 A
5626678 Sahin et al. May 1997 A
5633073 Cheung et al. May 1997 A
5660682 Zhao et al. Aug 1997 A
5707485 Rolfson et al. Jan 1998 A
5767021 Imai et al. Jun 1998 A
5792269 Deacon et al. Aug 1998 A
5811358 Tseng et al. Sep 1998 A
5814155 Solis et al. Sep 1998 A
5817406 Cheung et al. Oct 1998 A
5820685 Kurihara et al. Oct 1998 A
5830775 Maa et al. Nov 1998 A
5844195 Fairbairn et al. Dec 1998 A
5900351 Lutsic et al. May 1999 A
5908672 Ryu et al. Jun 1999 A
5911834 Fairbairn et al. Jun 1999 A
5968324 Cheung et al. Oct 1999 A
5980770 Ramachandran et al. Nov 1999 A
6013574 Hause et al. Jan 2000 A
6030901 Hopper et al. Feb 2000 A
6039834 Tanaka et al. Mar 2000 A
6045618 Raoux et al. Apr 2000 A
6054379 Yau et al. Apr 2000 A
6072227 Yau et al. Jun 2000 A
6077764 Sugiarto et al. Jun 2000 A
6083852 Cheung et al. Jul 2000 A
6086952 Lang et al. Jul 2000 A
6098568 Raoux et al. Aug 2000 A
6107184 Mandal et al. Aug 2000 A
6125788 Hills et al. Oct 2000 A
6127262 Huang et al. Oct 2000 A
6129091 Lee et al. Oct 2000 A
6130166 Yeh Oct 2000 A
6156149 Cheung et al. Dec 2000 A
6162323 Koshimizu Dec 2000 A
6171945 Mandal et al. Jan 2001 B1
6177347 Liu et al. Jan 2001 B1
6184134 Chaudhary et al. Feb 2001 B1
6187072 Cheung et al. Feb 2001 B1
6193802 Pang et al. Feb 2001 B1
6194628 Pang et al. Feb 2001 B1
6203657 Collison et al. Mar 2001 B1
6204192 Zhao et al. Mar 2001 B1
6209484 Huang et al. Apr 2001 B1
6230652 Tanaka et al. May 2001 B1
6242350 Tao et al. Jun 2001 B1
6245690 Yau et al. Jun 2001 B1
6277733 Smith Aug 2001 B1
6281135 Han et al. Aug 2001 B1
6287990 Cheung et al. Sep 2001 B1
6303523 Cheung et al. Oct 2001 B2
6306564 Mullee Oct 2001 B1
6319842 Khosla et al. Nov 2001 B1
6324439 Cheung et al. Nov 2001 B1
6340435 Bjorkman et al. Jan 2002 B1
6342446 Smith et al. Jan 2002 B1
6348725 Cheung et al. Feb 2002 B2
6350701 Yamazaki Feb 2002 B1
6358573 Raoux et al. Mar 2002 B1
6361707 Tanaka et al. Mar 2002 B1
6365516 Frenkel et al. Apr 2002 B1
6395092 Sugiarto et al. May 2002 B1
6413583 Moghadam et al. Jul 2002 B1
6426304 Chien et al. Jul 2002 B1
6432830 Merry Aug 2002 B1
6448187 Yau et al. Sep 2002 B2
6465964 Taguchi et al. Oct 2002 B1
6511903 Yau et al. Jan 2003 B1
6511909 Yau et al. Jan 2003 B1
6517913 Cheung et al. Feb 2003 B1
6537422 Sakuma et al. Mar 2003 B2
6537929 Cheung et al. Mar 2003 B1
6541282 Cheung et al. Apr 2003 B1
6555472 Aminpur Apr 2003 B2
6562544 Cheung et al. May 2003 B1
6562690 Cheung et al. May 2003 B1
6569257 Nguyen et al. May 2003 B1
6593247 Huang et al. Jul 2003 B1
6596655 Cheung et al. Jul 2003 B1
6632735 Yau et al. Oct 2003 B2
6638875 Han et al. Oct 2003 B2
6656832 Pan et al. Dec 2003 B1
6660656 Cheung et al. Dec 2003 B2
6660663 Cheung et al. Dec 2003 B1
6663715 Yuda et al. Dec 2003 B1
6667244 Cox et al. Dec 2003 B1
6669858 Bjorkman et al. Dec 2003 B2
6680164 Nguyen et al. Jan 2004 B2
6680420 Pang et al. Jan 2004 B2
6689930 Pang et al. Feb 2004 B1
6693043 Li et al. Feb 2004 B1
6709715 Lang et al. Mar 2004 B1
6720132 Tsai et al. Apr 2004 B2
6730593 Yau et al. May 2004 B2
6734115 Cheung et al. May 2004 B2
6743737 Yau et al. Jun 2004 B2
6764940 Rozbicki et al. Jul 2004 B1
6770556 Yau et al. Aug 2004 B2
6787452 Sudijono et al. Sep 2004 B2
6797188 Shen et al. Sep 2004 B1
6800571 Chcung et al. Oct 2004 B2
6806207 Huang et al. Oct 2004 B2
6837967 Berman et al. Jan 2005 B1
6848455 Shrinivisan et al. Feb 2005 B1
6858153 Bjorkman et al. Feb 2005 B2
6869896 Cheung et al. Mar 2005 B2
6900135 Somekh et al. May 2005 B2
6902682 Shang et al. Jun 2005 B2
6930061 Cheung et al. Aug 2005 B2
7023092 Yau et al. Apr 2006 B2
7070657 Cheung et al. Jul 2006 B1
7074298 Gondhalekar et al. Jul 2006 B2
7160821 Huang et al. Jan 2007 B2
7186648 Rozbicki et al. Mar 2007 B1
7202176 Goto et al. Apr 2007 B1
7205249 Cheung et al. Apr 2007 B2
7227244 Bjorkman et al. Jun 2007 B2
7256134 Kim et al. Aug 2007 B2
7288484 Goto et al. Oct 2007 B1
7297635 Toda et al. Nov 2007 B2
7344993 Balasubramaniam et al. Mar 2008 B2
7390755 Chen et al. Jun 2008 B1
7432209 Delgadino et al. Oct 2008 B2
7465680 Chen et al. Dec 2008 B2
7468326 Chen et al. Dec 2008 B2
7556712 Yi et al. Jul 2009 B2
7560377 Cheung et al. Jul 2009 B2
7569492 Chen et al. Aug 2009 B1
7585777 Goto et al. Sep 2009 B1
7595005 Balasubramaniam Sep 2009 B2
7597816 Chang et al. Oct 2009 B2
7601272 Nguyen et al. Oct 2009 B2
7628864 Moriya et al. Dec 2009 B2
7651949 Jo Jan 2010 B2
7740768 Goto et al. Jun 2010 B1
8034176 Tsukamoto et al. Oct 2011 B2
8058178 Goto et al. Nov 2011 B1
8058181 Chen et al. Nov 2011 B1
8097527 Yang Jan 2012 B2
8129281 Cheung et al. Mar 2012 B1
8193096 Goto et al. Jun 2012 B2
8435895 Chen et al. May 2013 B2
8444869 Goto et al. May 2013 B1
8591661 Cheung et al. Nov 2013 B2
20010014529 Chen et al. Aug 2001 A1
20010027023 Ishihara Oct 2001 A1
20020000202 Yuda et al. Jan 2002 A1
20020005392 Luo et al. Jan 2002 A1
20020039625 Powell et al. Apr 2002 A1
20020045331 Aminpur Apr 2002 A1
20020072016 Chen et al. Jun 2002 A1
20020078976 Nguyen Jun 2002 A1
20020081854 Morrow et al. Jun 2002 A1
20020090827 Yokoshima Jul 2002 A1
20020111041 Annapragada et al. Aug 2002 A1
20020132486 Williams et al. Sep 2002 A1
20020139775 Chang et al. Oct 2002 A1
20020185151 Qingyuan et al. Dec 2002 A1
20020185226 Lea et al. Dec 2002 A1
20020187643 Gu et al. Dec 2002 A1
20020197870 Johnson Dec 2002 A1
20030036284 Chou et al. Feb 2003 A1
20030045115 Fang Mar 2003 A1
20030045131 Verbeke et al. Mar 2003 A1
20040084412 Waldfried et al. May 2004 A1
20040237997 Rui et al. Dec 2004 A1
20040245091 Karim et al. Dec 2004 A1
20040248414 Tsai et al. Dec 2004 A1
20050079723 Niimi et al. Apr 2005 A1
20050106888 Chiu et al. May 2005 A1
20050158667 Nguyen et al. Jul 2005 A1
20050196967 Savas et al. Sep 2005 A1
20060046482 Verhaverbeke Mar 2006 A1
20060102197 Chiang et al. May 2006 A1
20060138399 Itano et al. Jun 2006 A1
20060154471 Minami Jul 2006 A1
20060163202 Shimizu Jul 2006 A1
20060182875 Ose et al. Aug 2006 A1
20060191478 Gondhalekar et al. Aug 2006 A1
20060201623 Yoo Sep 2006 A1
20060289384 Pavel et al. Dec 2006 A1
20070037396 Verhaverbeke Feb 2007 A1
20070040172 Kawakami et al. Feb 2007 A1
20070068900 Kim et al. Mar 2007 A1
20070144673 Yeom Jun 2007 A1
20070173066 Kokura et al. Jul 2007 A1
20070178698 Okita et al. Aug 2007 A1
20070224826 Delgadino et al. Sep 2007 A1
20070235137 Tsukamoto et al. Oct 2007 A1
20070281491 Kamp Dec 2007 A1
20080026589 Hubacek et al. Jan 2008 A1
20080044995 Kang et al. Feb 2008 A1
20080102646 Kawaguchi et al. May 2008 A1
20080160729 Krueger et al. Jul 2008 A1
20080248656 Chen et al. Oct 2008 A1
20080286697 Verhaverbeke et al. Nov 2008 A1
20090053901 Goto et al. Feb 2009 A1
20090056875 Goto et al. Mar 2009 A1
20090061623 Chang et al. Mar 2009 A1
20090200268 Tappan et al. Aug 2009 A1
20090221148 Udo et al. Sep 2009 A1
20090277871 Berry et al. Nov 2009 A1
20100015812 Nishikawa Jan 2010 A1
20100062591 Lin et al. Mar 2010 A1
20100216312 Yamamoto et al. Aug 2010 A1
20100308463 Yu et al. Dec 2010 A1
20110006034 Hilkene et al. Jan 2011 A1
20110139175 Cheung et al. Jun 2011 A1
20110139176 Cheung et al. Jun 2011 A1
20110143548 Cheung et al. Jun 2011 A1
20120211473 Goto et al. Aug 2012 A1
20130048014 Shaviv et al. Feb 2013 A1
20130157465 Chen et al. Jun 2013 A1
Foreign Referenced Citations (20)
Number Date Country
1402316 Mar 2003 CN
1720349 Jan 2006 CN
1868043 Nov 2006 CN
101015042 Aug 2007 CN
101131928 Feb 2008 CN
0 304 068 Feb 1989 EP
1 077 476 Feb 2001 EP
1081754 Jul 2001 EP
2001-308078 Nov 2001 JP
2003-264170 Sep 2003 JP
2007019367 Jan 2007 JP
2007-53344 Mar 2007 JP
2007266610 Oct 2007 JP
WO 2004051702 Jun 2004 WO
WO 2005017983 Feb 2005 WO
WO 2006028858 Mar 2006 WO
2011071980 Jun 2011 WO
2011072042 Jun 2011 WO
2011072061 Jun 2011 WO
WO 2012018375 Feb 2012 WO
Non-Patent Literature Citations (118)
Entry
Kikuchi et al., Native Oxide Removal on Si Surfaces by NF3-Added Hydrogen and Water Vapor Plasma Downstream Treatment, Jpn J. Appl. Phys. vol. 33 (1994), pp. 2207-2211, Part 1, No. 4B, Apr. 1994.
Woody K. Chung, “Downstream Plasma Removal of Mobile Ion Impurity From SIO2”, Published Proceedings of the 8th International Plasma Processing Symposium, Fall 1990, 7 pages.
Woody K, Chung, “Low Damage, Downstream RF Plasma Ashing of High Energy, Heavily Doped Implanted Resists,” Semicon Korea, Dec. 1989.
A. Kalnitsky and W. K. Chung, “Characterization and Optimization of a Single Wafer Downstream Plasma Stripper,” Journal of the Electrochemical Society, vol. 135, No. 9, Sep. 1988, pp. 2338-2341.
Goto et al., “Enhanced Stripping of Low-K Films Using Downstream Gas Mixing,” Novellus Systems, Inc., U.S. Appl. No. 10/890,653, filed Jul. 13, 2004.
U.S. Office Action for U.S. Appl. No. 10/890,653 mailed Jul. 27, 2005.
U.S. Final Office Action for U.S. Appl. No. 10/890,653 mailed Jan. 10, 2006.
U.S. Office Action for U.S. Appl. No. 10/890,653 mailed Jun. 26, 2006.
U.S. Office Action for U.S. Appl. No. 10/890,653 mailed Oct. 11, 2006.
U.S. Office Action for U.S. Appl. No. 10/890,653 mailed Apr. 5, 2007.
Notice of Allowance for U.S. Appl. No. 10/890,653 mailed Jun. 15, 2007.
Allowed Claims for U.S. Appl. No. 10/890,653.
Supplemental Notice of Allowance for U.S. Appl. No. 10/890,653 mailed Jul. 23, 2007.
Goto et al , “Enhanced Stripping of Low-K Films Using Downstream Gas Mixing,” Novellus Systems, Inc., U.S. Appl. No. 11/011,273, filed Dec. 13, 2004.
Notice of Allowance for U.S. Appl. No. 11/011,273 mailed Nov. 28, 2006.
Allowed Claims for U.S. Appl. No. 11/011,273.
Goto et al , “Enhanced Stripping of Low-K Films Using Downstream Gas Mixing,” Novellus Systems, Inc., U.S. Appl. No. 11/712,253, filed Feb. 27, 2007, pp. 1-28.
U.S. Office Action for U.S. Appl. No. 11/712,253 mailed Dec. 23, 2008.
Goto, et al., “Photoresist Strip Method for Low-K Dielectrics,” U.S. Appl. No. 11/859,727, filed Sep. 21, 2007.
U.S. Office Action for U.S. Appl. No. 11/859,727 mailed Oct. 6, 2008.
Notice of Allowance for U.S. Appl. No. 11/859,727 mailed May 1, 2009.
Allowed Claims for U.S. Appl. No. 11/859,727.
Goto, et al., “High Dose Implantation Strip (HDIS) in H2 Base Chemistry,” Novellus Systems, Inc., U.S. Appl. No. 12/251,305, filed Oct. 14, 2008.
Goto, et al., “Photoresist Strip Method for Low-K Dielectrics,” U.S. Appl. No. 12/533,461, filed Jul. 31, 2009.
U.S. Office Action for U.S. Appl. No. 11/712,253 mailed Jul. 17, 2009.
Chen, et al., “Method for Post-Etch Cleans,” U.S. Appl. No. 10/137,096, May 1, 2002.
U.S. Office Action for U.S. Appl. No. 10/137,096 mailed Jul. 11, 2003.
U.S. Final Office Action for U.S. Appl. No. 10/137,096 mailed Jul. 27, 2007.
Notice of Allowance for U.S. Appl. No. 10/137,096 mailed Jan. 15, 2008.
Allowed Claims for U.S. Appl. No. 10/137,096.
Chen, et al., “Method for Post-Etch Cleans,” U.S. Appl. No. 12/111,095, filed Aug. 28, 2008.
U.S. Office Action for U.S. Appl. No. 12/111,095 mailed Aug. 25, 2008.
Notice of Allowance for U.S. Appl. No. 12/111,095 mailed Apr. 3, 2009.
Allowed Claims for U.S. Appl. No. 12/111,095.
Chen, et al., “Method for Post-Etch Cleans,” U.S. Appl. No. 12/502,130, filed Jul. 31, 2009.
U.S. Office Action for U.S. Appl. No. 11/712,253 mailed Jan. 29, 2010.
Notice of Allowance for U.S. Appl. No. 11/548,801 mailed Feb. 17, 2010.
Cheung, et al., “Plasma Based Photoresist Removal System for Cleaning Post Ash Residue,” U.S. Appl. No. 11/128,930, filed May 12, 2005.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Sep. 13, 2006.
U.S. Final Office Action for U.S. Appl. No. 11/128,930 mailed Mar. 8, 2007.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Mar. 19, 2007.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Jun. 29, 2007.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Dec. 10, 2007.
U.S. Final Office Action for U.S. Appl. No. 11/128,930 mailed Jul. 21, 2008.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Mar. 20, 2009.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Sep. 17, 2009.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed Feb. 26, 2010.
U.S. Final Office Action for U.S. Appl. No. 11/128,930 mailed Sep. 9, 2010.
S. Wolf and R.N. Tauber, (Silicon Processing for the VLSI Era, vol. 1—Process Technology, Lattice Press, 1986), pp. 539-543.
U.S. Office Action for U.S. Appl. No. 12/533,461 mailed Nov. 5, 2010.
U.S. Office Action for U.S. Appl. No. 12/502,130 mailed Dec. 8, 2010.
Cheung, et al. “Ultra Low Silicon Loss High Dose Implant Strip,” U.S. Appl. No. 12/636,582, filed Dec. 11, 2009.
Cheung, et al. “Low Damage Photoresist Strip Method for Low-K Dielectrics,” U.S. Appl. No. 12/636,601, filed Dec. 11, 2009.
U.S. Office Action for U.S. Appl. No. 11/712,253 mailed Mar. 1, 2011.
U.S. Office Action for U.S. Appl. No. 12/251,305 mailed Nov. 2, 2011.
U.S. Office Action for U.S. Appl. No. 12/786,230 mailed Nov. 10, 2011.
Notice of Allowance for U.S. Appl. No. 11/128,930 mailed Oct. 28, 2011.
Chen, et al., “Methods for Stripping Photoresist and/or Cleaning Metal Regions,” U.S. Appl. No. 11/696,633, filed Apr. 7, 2007.
Office Action mailed Dec. 15, 2009, for U.S. Appl. No. 11/696,633.
Office Action mailed May 26, 2010, for U.S. Appl. No. 11/696,633.
Final Office Action mailed Sep. 20, 2010, for U.S. Appl. No. 11/696,633.
Office Action mailed Jun. 6, 2011, for U.S. Appl. No. 11/696,633.
Final Office Action mailed Sep. 28, 2011, for U.S. Appl. No. 11/696,633.
Office Action mailed Jan. 27, 2012, for U.S. Appl. No. 11/696,633.
Notice of Allowance for U.S. Appl. No. 12/251,305 mailed Feb. 17, 2012.
U.S. Final Office Action for U.S. Appl. No. 12/786,230 mailed Apr. 26, 2012.
Singapore Written Opinion and Search Report mailed Feb. 2, 2012, for Application No. 201104086-2.
Office Action mailed Mar. 30, 2012, for U.S. Appl. No. 12/636,601.
Goto, et al., “High Dose Implantation Strip (HDIS) in H2 Base Chemistry,” Novellus Systems, Inc., U.S. Appl. No. 13/462,660, filed May 2, 2012.
Final Office Action mailed May 15, 2012, for U.S. Appl. No. 11/696,633.
Goto et al , “Enhanced Stripping of Low-K Films Using Downstream Gas Mixing,” Novellus Systems, Inc., U.S. Appl. No. 10/890,653, filed Jul. 13, 2004.
Goto, et al., “High Dose Implantation Strip (HDTS) in H2 Base Chemistry,” Novellus Systems, Inc., U.S. Appl. No. 12/251,305, filed Oct. 14, 2008.
Cheung, et al. “Enhanced Passivation Process to Protect Silicon Prior to High Dose Implant Strip,” U.S. Appl. No. 12/963,503, filed Dec. 8, 2009.
U.S. Office Action for U.S. Appl. No. 11/128,930 mailed May 10, 2011.
U.S. Final Office Action for U.S. Appl. No. 12/533,461 mailed May 26, 2011.
International Search Report and Written Opinion for Application No. PCT/US2010/059388 mailed Jun. 27, 2011.
International Search Report and Written Opinion for Application No. PCT/US2010/059547 mailed Jul. 13, 2011.
International Search Report and Written Opinion for Application No. PCT/US2010/059517 mailed Jul. 14, 2011.
Notice of Allowance for U.S. Appl. No. 12/533,461 mailed Aug. 12, 2011.
Allowed Claims as of Aug. 12, 2011 for U.S. Appl. No. 12/533,461.
Notice of Allowance for U.S. Appl. No. 12/502,130 mailed Aug. 12, 2011.
Allowed Claims as of Aug. 12, 2011 for U.S. Appl. No. 12/502,130.
U.S. Appl. No. 12/786,230, filed May 24, 2010, entitled “Simultaneous Front Side Ash and Backside Clean”.
U.S. Appl. No. 12/963,503, filed Dec. 8, 2010, entitled “Enhanced Passivation Process to Protect Silicon Prior to High Dose Implant Strip”.
U.S. Appl. No. 13/274,638, filed Oct. 17, 2011, entitled “Photoresist Strip Method for Low-K Dielectrics.”
U.S. Appl. No. 13/370,689, filed Feb. 10, 2012, entitled “Plasma Based Photoresist Removal System for Cleaning Post Ash Residue”.
U.S. Appl. No. 13/590,083, filed Aug. 20, 2012, entitled “Photoresist Strip Processes for Improved Device Integrity”.
US Office Action, dated Sep. 6, 2012, issued in U.S. Appl. No. 12/636,582.
US Final Office Action, dated Sep. 5, 2012, issued in U.S. Appl. No. 12/636,601.
US Final Office Action, dated May 15, 2012, issued in U.S. Appl. No. 11/696,633.
Notice of Allowance, dated Oct. 29, 2012, issued in U.S. Appl. No. 11/696,633.
Singapore Written Opinion, dated Feb. 2, 2012, issued in Application No. 201104086-2.
Singapore Second Written Opinion, dated Aug. 17, 2012, issued in Application No. 201104086-2.
Japanese Office Action mailed Sep. 25, 2012, issued in Application No. 2009-018046.
Chinese Office Action mailed Jul. 20, 2012, issued in Application No. 200810187894.4.
U.S. Appl. No. 14/066,587, filed Oct. 29, 2013, entitled “Low Damage Photoresist Strip Method for Low-K Dielectrics.”
US Office Action dated Feb. 15, 2013, U.S. Appl. No. 13/274,638.
US Office Action, dated Apr. 26, 2013, issued in U.S. Appl. No. 13/462,660.
US Notice of Allowance, dated Sep. 30, 2013, issued in U.S. Appl. No. 13/462,660.
US Final Office Action, dated May 13, 2013, issued in U.S. Appl. No. 12/636,582.
US Office Action, dated Feb. 12, 2013, issued in U.S. Appl. No. 12/636,601.
US Notice of Allowance, dated Jul. 23, 2013, issued in U.S. Appl. No. 12/636,601.
US Notice of Allowance dated Jan. 24, 2013, issued in U.S. Appl. No. 12/786,230.
US Office Action dated Feb. 22, 2013, issued in U.S. Appl. No. 13/370,689.
US Final Office Action dated Aug. 20, 2013, issued in U.S. Appl. No. 13/370,689.
US Office Action, dated Jul. 19, 2013, issued in U.S. Appl. No. 13/759,958.
US Final Office Action, dated Nov. 12, 2013, issued in U.S. Appl. No. 13/759,958.
Chinese Office Action dated Jun. 19, 2013, issued in Application No. 200810187894.4.
Japanese Description of details of Reasons for Rejection dated Oct. 9, 2012, issued in Application No. 2009-018046.
Japanese Summary of Reasons for Rejection dated Sep. 3, 2013, issued in Application No. 2009-018046.
PCT International Preliminary Report on Patentability and Written Opinion, dated Jun. 21, 2012, issued in Application No. PCT/US2010/059388.
PCT International Preliminary Report on Patentability and Written Opinion, dated Jun. 21, 2012, issued in Application No. PCT/US2010/059517.
Singapore Written Opinion, dated Jul. 15, 2013, issued in Application No. 201204092-9.
PCT International Preliminary Report on Patentability and Written Opinion, dated Jun. 21, 2012, issued in Application No. PCT/US2010/059547.
Singapore Office Action dated Aug. 1, 2013 issued in Applivcation No. 201203361-9.
European Partial Search Report dated Apr. 17, 2013 issued in Application No. 12 18 1659.
European Partial Search Report dated Aug. 19, 2013 issued in Application No. 12 18 1659.
Ghandhi, Sorab K., (1983) “VLSI Fabrication Principles,” by John wiley & Sons, Inc., pp. 517-520.
Related Publications (1)
Number Date Country
20110139175 A1 Jun 2011 US
Provisional Applications (1)
Number Date Country
61285918 Dec 2009 US